Asset Management Resources’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,588
Closed -$174K 64
2023
Q3
$174K Buy
11,588
+3,560
+44% +$74.1K 0.11% 57
2023
Q2
$261K Buy
8,028
+2,321
+41% +$84.8K 0.16% 49
2023
Q1
$223K Buy
5,707
+235
+4% +$11.5K 0.14% 51
2022
Q4
$289K Sell
5,472
-711
-11% -$34.6K 0.2% 41
2022
Q3
$278K Buy
6,183
+270
+5% +$11.6K 0.27% 38
2022
Q2
$215K Buy
5,913
+905
+18% +$32.9K 0.18% 49
2022
Q1
$207K Buy
5,008
+226
+5% +$7.95K 0.17% 57
2021
Q4
$204K Buy
+4,782
New +$239K 0.18% 56

Other funds holding SILK

Asset Management Resources's SILK Position: Q4 2023 in Review

Asset Management Resources sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 11,588 shares — an estimated $174K sold.

Asset Management Resources first reported a position in SILK in Q4 2021 and held it in 8 quarters. The position peaked at $289K in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Asset Management Resources reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Asset Management Resources sold 11,588 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $174K.
  • Asset Management Resources first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Asset Management Resources's Silk Road Medical, Inc. Common Stock position peaked at $289K in Q4 2022.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Asset Management Resources's 13F filing for Q4 2023, filed 25 Jan 2024.